In addition, TGF-β1 treatment has been found to induce mesenchymal features in CCA cell lines (CCKS-1 and TFK-1), correlated with the downregulation of E-cad mRNA expression and an increase in Snail expression [29]. The gene discussed is SNAI1; the disease is cholangiocarcinoma.